EQ | Equillium, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5800 - 0.6140
52 Week Range	0.5600 - 3.25
Beta	1.40
Implied Volatility	474.43%
IV Rank	75.68%
Day's Volume	108,772
Average Volume	173,387
Shares Outstanding	35,430,800
Market Cap	21,541,926
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-10-12

Valuation
Profitability
Growth
Health
P/E Ratio	-5.07
Forward P/E Ratio	N/A
EPS	-0.12
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	45
Country	USA
Website	EQ

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

EQ's peers: LYRA, HOOK, LIAN, JSPR, CINGW, SABS, ANEB, CVKD, MNPR, SPRO, BOLT, CHRS, GRCL, NLTX, IKNA, HOWL, EWTX, QNRX, KTTA, LIFE, TRVI, CUE, ANTX, BCAB

*Chart delayed

Analyzing fundamentals for EQ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see EQ Fundamentals page.

Watching at EQ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on EQ Technicals page.